Advanced search×


Print ISSN
Electronic ISSN
Impact factor
Usage rank
Article count
Free count
Free percentage
PDFs via platforms
Proquest, Rcgp, CSA, Ingenta, Wiley from 1948, Gale, and Ovid from 2005

  1. Issue information.
    Author(s) unavailable

    Cancer 120 Suppl 16:i (2014) PMID 25099908

  2. Patterns of recurrence after trimodality therapy for esophageal cancer.

    Cancer 120(14):2099 (2014) PMID 24711267

    Patterns of failure after neoadjuvant chemoradiotherapy and surgery for esophageal cancer are poorly defined. All patients in the current study were treated with trimodality therapy for nonmetastatic esophageal cancer from 1995 to 2009. Locoregional failure included lymph node failure (NF), anastomo...
  3. Determinants of alpha-fetoprotein levels in patients with hepatocellular carcinoma: implications for its clinical use.

    Cancer 120(14):2150 (2014) PMID 24723129

    α-Fetoprotein (AFP) is a biomarker commonly used in the management of patients with hepatocellular carcinoma (HCC), although the possible determinants of its serum levels in these patients have not been adequately explored. For this study, the authors evaluated the relevance of demographic, clinical...
  4. Consensus statement released for treating melanoma patients with immunotherapy.

    Cancer 120(1):3 (2014) PMID 24347380

  5. Dramatic rise in skin cancer seen in young adults.

    Cancer 118(16):3881 (2012) PMID 22864931

  6. The role of technetium-99m methoxyisobutyl isonitrile scintigraphy in predicting the therapeutic effect of chemotherapy against nasopharynge...

    Cancer 117(11):2435 (2011) PMID 21157943

    : Patients with negative (99m)Tc-MIBI accumulation were resistant to 5-FU/DDP chemotherapy. (99m)Tc-MIBI imaging in patients with NPC was capable of predicting tumor response to chemotherapy with 5-FU/DDP and can help in the selection of patients for induction chemotherapy. Cancer 2011. © 2010 Ameri...
  7. Three national cancer clinical research groups to merge.
    Author(s) unavailable

    Cancer 117(10):2018 (2011) PMID 21523710

  8. Reply to Intra-arterial chemotherapy for head and neck cancer

    Cancer 117(4):874 (2011) PMID 20922789

  9. Thanks to authors and peer reviewers.
    Author(s) unavailable

    Cancer 116(24):5789 (2010) PMID 21218462

  10. Sunitinib rechallenge in metastatic renal cell carcinoma patients

    Cancer 116(23):5400 (2011) PMID 21046646

    : Sunitinib rechallenge had potential benefits and was tolerated in select metastatic RCC patients. Additional prospective investigation was warranted. Cancer 2010. © 2010 American Cancer Society....